https://www.neurologyadvisor.com/topics/neuromuscular-disorders/rituximab-reduces-risk-disease-manifestation-new-onset-myasthenia-gravis/
0
0
Rituximab Reduces Risk for Disease Manifestation in New-Onset Myasthenia Gravis - Neurology Advisor
10/18/22 at 3:06pm
Organization
Neurologyadvisor.com
Author
Emily Estrada
34 words
0
Comments
In a randomized clinical trial, researchers investigated the efficacy and safety of rituximab compared with placebo for patients with myasthenia gravis.
You are the first to view
Create an account or login to join the discussion